Fifty 410 review
The cheapest compounded tirzepatide entry point we have verified — $133/month, on a two-tier price that doubles the dose question
Reviewed September 18, 2026 · Visit Fifty 410
Overview
What Fifty 410 is
Fifty 410 sells compounded tirzepatide at $133 a month on a three-month starter plan, which is the lowest tirzepatide figure we have verified anywhere — below CoreAge Rx's $129 flat rate and less than a third of Coby Health's maintenance price. The catch is in the second row of its own price table: a separate High Dose plan at $183 a month. So the price is not flat, it is banded, and the $133 buys the starter dosing protocol rather than the treatment most people end up on. Payment is unusually flexible, with Afterpay, Affirm and FSA/HSA all accepted, and the intake is genuinely free — no credit card, and you pay only if approved.
Treatment options
- Compounded tirzepatide injections
Branded vs compounded
Compounded only
Dispenses compounded preparations from compounding pharmacies. Substantially cheaper; not FDA-approved products, and not evaluated by FDA for safety, efficacy, or quality.
Branded medications
None offered
Compounded medications
- Compounded tirzepatide (injection)
Best for
Cost-focused buyers happy with a three-month commitment who will establish which dose band their protocol falls into first.
Limitations
The headline is the cheapest in this market and the structure is the reason. Ask which doses the starter protocol actually covers and what triggers the move to the high-dose plan, because that boundary is where the advertised saving is decided. Buy-now-pay-later on a chronic medication also deserves thought: instalment debt on a treatment you may take for years is a different commitment from instalment debt on a sofa.
Pricing
What it costs
Every figure below is published by the provider. Where a price is not published, we say so rather than estimating.
What the membership includes
- Provider consultation
- Compounded tirzepatide
- Free shipping
| Medication | Published price | Note |
|---|---|---|
| Compounded tirzepatide — starter protocol | $133/mo | $399 total for three months. Starter dosing protocol |
| Compounded tirzepatide — high dose protocol | $183/mo | $549 total for three months. Advanced dosing protocol |
How it works
Process, eligibility and logistics
- Consultation process
- A five-minute online health form requiring no credit card, reviewed by a licensed clinician who recommends a treatment plan. You pay only if approved, and medication ships free.
- Eligibility
- Treatment eligibility is determined by licensed healthcare providers based on an individual health assessment. Specific criteria are not published.
- Who prescribes
- Licensed clinicians reviewing each assessment. Fifty 410 states it is a telehealth platform and does not compound, manufacture or distribute medications itself.
- Lab requirements
- Not disclosed on the provider's site
- Ongoing support
- Not disclosed on the provider's site
- Nutrition & coaching
- Not disclosed on the provider's site
- Pharmacy fulfilment
- Independent FDA-registered 503A compounding pharmacies, described as preparing compounded formulations containing FDA-approved active pharmaceutical ingredients in compliance with federal and state regulations. Individual pharmacies are not named.
- Shipping
- Free shipping, included in both plans.
- Insurance
- Not disclosed on the provider's site
- HSA / FSA
- FSA and HSA accepted, alongside Afterpay and Affirm instalment payments.
- Cancellation
- Not disclosed on the provider's site
- Refunds
- You pay only if a provider approves treatment; no refund policy beyond that is published.
Assessment
Pros and cons
Editorial judgment applied to the published facts above.
Pros
- $133/month is the lowest compounded tirzepatide figure we have verified anywhere
- Free intake with no credit card, and you pay only if a provider approves treatment
- Buy-now-pay-later through Afterpay and Affirm, plus FSA/HSA — the widest payment flexibility we have seen
- States its pharmacies are independent, FDA-registered 503A facilities using FDA-approved active ingredients
- Publishes the compounded-medication disclaimer prominently rather than burying it
Cons
- Two-tier pricing: the $133 starter rate becomes $183 on the high-dose protocol, a 38% rise
- Neither tier states which doses it covers, so you cannot tell where the boundary falls
- Both plans are three-month commitments; no month-to-month option is published
- Pharmacies are not named, and no eligibility criteria, labs, cancellation or ongoing-support terms are published
- The brand voice is aimed squarely at a young audience, which sits oddly against a prescription-only medication
Alternatives
If Fifty 410 isn't right
CoreAge Rx
Compounded semaglutide from $79/month and tirzepatide from $129/month on 12-month plans; compare the full term before paying
None — no membership, sign-up or auto-rebill fees
Precision Telemed
Flat $249.99 from 2 mg to 15 mg, with its pharmacy named and eleven clinicians published with NPI numbers
None — no subscription, month-to-month only
SkinnyVIP
A veteran-owned Miami practice charging one flat $232 a month for any tirzepatide dose, with a refund if a clinician declines you
None — no membership, no auto-billing, no minimum commitment
Fifty 410: frequently asked questions
How much does Fifty 410 cost?
Is Fifty 410's price flat across doses?
Do I pay before seeing a provider?
Can I pay in instalments?
Sources
Verified September 18, 2026. Prices in this category change frequently — confirm current details with the provider.
Medical disclaimer
This review is editorial research about a commercial service. It is not medical advice, and it is not a recommendation to start, stop or change any treatment. GLP-1 medications are prescription drugs with real contraindications and side effects. Decisions about whether they are appropriate for you belong with a qualified clinician who knows your medical history. Prices and terms in this category change frequently — we publish the date each review was verified and link every source, but you should confirm current details with the provider before purchasing.